Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15496061rdf:typepubmed:Citationlld:pubmed
pubmed-article:15496061lifeskim:mentionsumls-concept:C0014630lld:lifeskim
pubmed-article:15496061lifeskim:mentionsumls-concept:C0596087lld:lifeskim
pubmed-article:15496061lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:15496061lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:15496061lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:15496061lifeskim:mentionsumls-concept:C1879748lld:lifeskim
pubmed-article:15496061lifeskim:mentionsumls-concept:C1706853lld:lifeskim
pubmed-article:15496061lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:15496061lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:15496061lifeskim:mentionsumls-concept:C0960892lld:lifeskim
pubmed-article:15496061pubmed:issue22lld:pubmed
pubmed-article:15496061pubmed:dateCreated2004-10-21lld:pubmed
pubmed-article:15496061pubmed:abstractText[reaction: see text] A series of structurally simplified luminacin analogues devoid of the epoxide ring are assembled in a stereocontrolled manner from 2,4-dimethoxybenzaldehyde using a syn-selective aldol reaction as the key step. The success of the approach is critically dependent on the nature and extent of the alcohol protecting groups. The synthetic analogues inhibit VEGF-stimulated angiogenesis in an in vitro assay indicating that the epoxide is not essential for biological activity in this compound class.lld:pubmed
pubmed-article:15496061pubmed:languageenglld:pubmed
pubmed-article:15496061pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15496061pubmed:statusPubMed-not-MEDLINElld:pubmed
pubmed-article:15496061pubmed:monthOctlld:pubmed
pubmed-article:15496061pubmed:issn1523-7060lld:pubmed
pubmed-article:15496061pubmed:authorpubmed-author:ShipmanMichae...lld:pubmed
pubmed-article:15496061pubmed:authorpubmed-author:DaviesMark...lld:pubmed
pubmed-article:15496061pubmed:authorpubmed-author:SlawinAlexand...lld:pubmed
pubmed-article:15496061pubmed:authorpubmed-author:WhatmoreJacqu...lld:pubmed
pubmed-article:15496061pubmed:authorpubmed-author:MaskellLesley...lld:pubmed
pubmed-article:15496061pubmed:authorpubmed-author:VidotSandrine...lld:pubmed
pubmed-article:15496061pubmed:issnTypePrintlld:pubmed
pubmed-article:15496061pubmed:day28lld:pubmed
pubmed-article:15496061pubmed:volume6lld:pubmed
pubmed-article:15496061pubmed:ownerNLMlld:pubmed
pubmed-article:15496061pubmed:authorsCompleteYlld:pubmed
pubmed-article:15496061pubmed:pagination3909-12lld:pubmed
pubmed-article:15496061pubmed:year2004lld:pubmed
pubmed-article:15496061pubmed:articleTitleStudies toward the synthesis of luminacin D: assembly of simplified analogues devoid of the epoxide displaying antiangiogenic activity.lld:pubmed
pubmed-article:15496061pubmed:affiliationDepartment of Chemistry, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK.lld:pubmed
pubmed-article:15496061pubmed:publicationTypeJournal Articlelld:pubmed